EX-23.1 3 brhc10049535_ex23-1.htm EXHIBIT 23.1
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm
 
We consent to the incorporation by reference in the registration statements (No. 333-251105 and No. 333-263913) on Form S-8 and in the registration statement (No. 333-261970) on Form S-3 of our report dated March 15, 2023, with respect to the consolidated financial statements of Kinnate Biopharma Inc.
 
/s/ KPMG LLP
 
San Diego, California
March 15, 2023